Hepatitis B prevents the annual market scale of vaccine from reaching 800 million yuan

Hepatitis B prevents the annual market scale of vaccine from reaching 800 million yuan
Vaccine of reporter Huan LuYi's liver has played a great role in dispelling hepatitis B and virus and infecting. Disease of Ministry of Public Health controls Deputy Bureau Director of the office Wang Bin to reveal at the customary meeting of Ministry of Public Health on the 9th, from 1992 to these 18 years of 2010, because hepatitis B vaccine will be immunized, China reduced about 80 million the infeted of hepatitis B and virus, the person who carries antigen of surface of children's hepatitis B reduces nearly 19 million people. According to the introduction of Wang Bin, at present, the whole world of the infeted of hepatitis B and virus is nearly 350 million, China is nearly 93 million. That is to say, China probably has a person who is infected with hepatitis B and virus in every 14 people. As to this, the wide scheme of partner's ginger of calm fund says to the reporter, the above-mentioned data explain, the space of market of vaccine of hepatitis B is enormous. The biological valley online company's Chairman Zhang FaBao introduces to the reporter, enterprises producing preventative vaccine at home at present mainly have Tiantan Bio-pharmaceuticals (600161, burst) , safe living beings, Chinese letter, gold smooth living beings and Ge Lan plain SmithKline, sell about No. 60 million Branch every year, market scale is about 800 million yuans every year. In the industry to expect to have therapeutic vaccine to go on the market in the future. It is introduced, vaccine of hepatitis B employed on clinic at present is mainly as follows, blood source hepatitis B vaccine, genetic engineering vaccine, suck before S the hepatitis B vaccines of the albumens.

|